Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease

AIDS

Volumn 12, Issue 12, 1998, Pages 1451-1457

  Sterling, Timothy R ^a   Moore, Richard D ^a   Graham, Neil M H ^b   Astemborski, Jacquie ^b   Vlahov, David ^b   Chaisson, Richard E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Drug users; M. avium complex; Mycobacterium tuberculosis; Opportunistic infections

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; TUBERCULOSIS;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBIOTIC PROPHYLAXIS; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TUBERCULOSIS;

EID: 0032552098     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199812000-00006     Document Type: Article

References (40)

1. Horsburgh Jr CR: Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991, 324:1332-1338.
2. Moore RD, Chaisson RE: Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 1996, 124:633-642.
3. Havlik Jr JA, Horsburgh Jr CR, Metchock B, Williams PP, Fann SA, Thompson SE: Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends. J Infect Dis 1992, 165:577-580.
4. Jacobson MA, Hopewell PC, Yajko DM, et al.: Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis 1991, 164:994-998.
5. Horsburgh Jr CR, Havlik JA, Ellis DA, et al.: Survival of patients with acquired immunodeficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy. Am Rev Respir Dis 1991, 144:557-559.
6. Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T: Incidence and natural history of Mycobacterium avium complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. Am Rev Respir Dis 1992, 146:285-289.
7. Chin DP, Rheingold A, Stone EN, et al.: The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients: a prospective study. J Infect Dis 1994, 170:578-584.
8. Nightingale SD, Byrd LT, Southern PM, Jockusch JD, Cal SX, Wynne BA: Incidence of Mycobacterium avium-intracellularae complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 1992, 165:1082-1085.
9. Gordin FM, Cohn DL, Sullam PM, Schoenfelder JR, Wynne BA, Horsburgh Jr CR: Early manifestations of disseminated Mycobacterium avium complex disease: a prospective evaluation. J Infect Dis 1997, 176:126-132.
10. Finkelstein DM, Williams PL, Molenhurghs G, et al.: Patterns of opportunistic infections in patients with HIV infection. J Acquir Immune Defic Syndr 1996, 12:38-45.
11. Horsburgh Jr CR, Selik RM: The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis 1989, 139:4-7
12. Yakrus MA, Good RC: Geographic distribution, frequency, and specimen source of M. avium complex serotypes isolated from patients with acquired immunodeficiency syndrome. J Clin Microbiol 1990, 28:926-929.
13. Horsburgh Jr CR, Schoenfelder JR, Gordin FM, Cohn DL, Sullam PM, Wynne BA: Geographic and seasonal variation in Mycobacterium avium bacteremia among North American patients with AIDS. Am J Med Sci 1997, 313:341-345.
14. Horsburgh Jr CR, Chin DP, Yajko DM, et al.: Environmental risk factors for acquisition of Mycobacterium avium complex in persons with human immunodeficiency virus infection. J Infect Dis 1994, 170:362-370.
15. Rosenzweig DY: Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex: clinical features and course in 100 consecutive cases. Chest 1979, 75:115-119.
16. Tsukamura M, Shimoide H, Kita N, et al.: Epidemiologic studies of lung disease due to mycobacteria other than Mycobacterium tuberculosis in Japan. Rev Infect Dis 1981, 3:997-1007.
17. Newport MJ, Huxley CM, Huston S, et al.: A mutation in the interferon gamma receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996, 335:1941-1949.
18. Horsburgh Jr CR, Hanson DL, Jones JL, Thompson SE: Protection from Mycobacterium avium complex disease in human immunodeficiency virus-infected persons with a history of tuberculosis. J Infect Dis 1996, 174:1212-1217.
19. Vlahov D, Anthony JC, Munoz A, et al.: The ALIVE study: a longitudinal study of HIV infection in intravenous drug users: description of methods. J Drug Issues 1991, 21:759-776.
20. Graham NMH, Nelson KE, Solomon L, et al.: Prevalence of tuberculin positivity and skin test anergy in HIV-1 seropositive and -seronegative intravenous drug users. JAMA 1992, 267:369-373.
21. Centers for Disease Control and Prevention: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41 (RR-17):1-19.
22. Centers for Disease Control and Prevention: Screening for tuberculosis and tuberculosis infection in high-risk populations: recommendations of the advisory council for the elimination of tuberculosis. MMWR 1995, 44 (RR-11):18-34.
23. American Thoracic Society: Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994, 149:1359-1374.
24. SAS Institute: SAS Version 6.12. Cary: SAS Institute, Inc.; 1996.
25. Raviglione MC, Snider Jr DE, Kochi A: Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 1995, 273:220-226.
26. Glassroth J: Vaccines for tuberculosis: the glass remains half empty. Ann Intern Med 1997, 127:403-404.
27. Stead WW: Management of health care workers after inadvertent exposure to tuberculosis: a guide for the use of preventive therapy. Ann Intern Med 1995, 122:906-912.
28. Wickman K: Clinical significance of nontuberculous mycobacteria. A bacteriological survey of Swedish strains isolated between 1973 and 1981. Scand J Infect Dis 1986, 18:337-344.
29. Katila ML, Brander E, Backman A: Neonatal BCG vaccination and mycobacterial cervical adenitis in childhood. Tubercle Lung Dis 1987, 68:291-296.
30. Trnka L, Dankova D, Svandova E: Six year' experience with the discontinuation of BCG vaccination. IV. Protective effect of BCG vaccination against Mycobacterium avium intracellularae complex. Tubercle Lung Dis 1994, 75:348-352.
31. Colditz GA, Brewer TF, Berkey CS, et al.: Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 1994, 274:698-703.
32. Marsh BJ, von Reyn CF, Edwards J, et al.: The risks and benefits of childhood BCG immunization among adults with AIDS. AIDS 1997, 11:669-672.
33. Fine PEM: Randomized controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 1996, 348:17-24.
34. Jones BE, Young SMM, Antoniskis D, Davidson PT, Kramer F, Barnes PF: Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency infection. Am Rev Respir Dis 1993, 148:1292-1297.
35. Perronne C, Ghoubontni A, Leport C, Salmon-Ceron D, Bricaire F, Vilde JL: Should pulmonary tuberculosis be an AIDS-defining diagnosis in patients infected with HIV? Tubercle Lung Dis 1992, 73:39-44.
36. Llibre JM, Tor J, Manterola JM, Carbonell C, Roset J: Risk stratification for dissemination of tuberculosis in HIV-infected patients QJM 1992, 298:149-157.
37. Sodhi A, Gong J, Silva C, Qian D, Barnes PF: Clinical correlates of interferon-gamma production in patients with tuberculosis. Clin Infect Dis 1997, 25:627-620.
38. Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE: Eleven years of community-based directly observed therapy for tuberculosis. JAMA 1995, 274:945-951.
39. Horsburgh Jr CR, Hanson DL, Jones JL: Does prior tuberculosis protect human immunodeficiency virus-infected persons from Mycobacterium avium complex disease? (Reply). J Infect Dis 1997, 176:1412-1413.
40. Converse PJ, Jones SL, Astemborski J, Vlahov D, Graham NMH: Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J Infect Dis 1997, 176:144-150.